NCT05326776View on ClinicalTrials.gov

Peripheral Oxytocin and Touch

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 5, 2023

Primary Completion Date

August 3, 2023

Study Completion Date

August 3, 2023

Conditions
Healthy Adults
Interventions
DRUG

Pitocin

At each session, 4mcg/2ml oxytocin or 2ml isotonic saline (0.9% sodium chloride; placebo control) will be injected into the middle of the dorsal forearm. Sessions will be separated by at least 48 hours to ensure drug clearance.

Trial Locations (1)

92115

ACTRI, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER